3-NAntC: A Potent Crotoxin B-Derived Peptide against the Triple-Negative MDA-MB-231 Breast Cancer Cell Line.

3-NAntC displayed superior anti-tumor activity in vitro compared to cisplatin and comparable activity to doxorubicin with more favorable tolerability.